Clinical trial Recruiting at 4 sites Observational

Registry comparing different drug-eluting stents for coronary artery disease

Official title: Prospective Registry for Patients Undergoing Coronary Angiography and Percutaneous Coronary Intervention in Gangwon Province

Run by Yonsei University · NCT02038127 · Data updated 2026-11-12

This study is testing how well different types of drug-eluting stents work for people with coronary artery disease who are getting heart procedures.

More Coronary Artery Disease trials

Quick facts

Study typeObservational
SexAll
Enrollment10000 (estimated)
SponsorYonsei University
Academic / other
Locations4 sites (Chuncheon, Gangwon-do and 3 other locations)
StatusRecruiting
StartedJanuary 1, 2013
Main results expectedDecember 31, 2030
Study endsDecember 31, 2031
Registry record updatedOctober 7, 2026
Trial IDNCT02038127 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include adults over 19 years with significant coronary artery stenosis and evidence of myocardial ischemia.

Probably not a fit

Patients with known hypersensitivity to the medications or materials used in the stents may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational registry aims to compare the effectiveness of various drug-eluting stents, including Biolimus-eluting, Everolimus-eluting, and Zotarolimus-eluting stents, in patients with coronary artery disease who are undergoing percutaneous coronary intervention. Participants must be over 19 years old and have significant coronary artery stenosis along with evidence of myocardial ischemia. The study will gather data on patient outcomes to evaluate the performance of these stents in a real-world clinical setting.

Why it matters

Potential benefit: If successful, this study could lead to improved treatment strategies for patients with coronary artery disease, enhancing stent selection and patient outcomes.

How similar studies have gone: Other studies have shown success in comparing drug-eluting stents, indicating that this approach is supported by prior research.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients of any age undergoing percutaneous coronary intervention (PCI) at a participating hospital during the study period.
* Written informed consent is obtained from the patient or a legally authorized representative before collection of study data, unless the requirement for informed consent is waived by the Institutional Review Board.

Exclusion Criteria:

* Refusal or withdrawal of informed consent, when informed consent is required.
* No PCI performed during the index hospital encounter.

Where it's running

  • Chuncheon Hallym University Hospital
    Chuncheon, Gangwon-do, South Korea
    Recruiting
  • Kangwon National University Hospital
    Chuncheon, Gangwon-do, South Korea
    Recruiting
  • Gangneung Asan Hospital
    Gangneung, Gangwon-do, South Korea
    Recruiting
  • Wonju Severance Christian Hospital
    Wŏnju, Gangwon-do, South Korea
    Recruiting

Study contacts

  • Principal investigator: Young Jin Youn, M.D., Ph.D. — Yonsei University
  • Study coordinator: Young Jin Youn, M.D., Ph.D.
  • Email: younyj@yonsei.ac.kr
  • Phone: +82-33-741-0917

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.